Europe Recombinant Protein Market Report 2016
VISIT HERE @ http://www.grandresearchstore.com/pharmaceuticals/europe-recombinant-protein-market-report-2016 This report provided by grandresearchstore is about , Recombinant Protein in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Pfizer, Inc. (US), Bayer HealthCare Pharmaceuticals, Inc. (US), GlaxoSmithKline (UK), AbbVie, Inc. (US), Anavex Life Sciences Corp. (US),..
VISIT HERE @ http://www.grandresearchstore.com/pharmaceuticals/europe-recombinant-protein-market-report-2016
This report provided by grandresearchstore is about , Recombinant Protein in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Pfizer, Inc. (US),
Bayer HealthCare Pharmaceuticals, Inc. (US),
GlaxoSmithKline (UK),
AbbVie, Inc. (US),
Anavex Life Sciences Corp. (US),..
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
10.6.2.1 Type I<br />
10.6.2.2 Type II<br />
10.6.3 Baxter International, Inc. (US) <strong>Recombinant</strong> <strong>Protein</strong> Sales, Revenue, Price and Gross<br />
Margin (2011-<strong>2016</strong>)<br />
10.6.4 Main Business/Business Overview<br />
10.7 Biocon (India)<br />
10.7.1 Company Basic Information, Manufacturing Base and Competitors<br />
10.7.2 <strong>Recombinant</strong> <strong>Protein</strong> Product Type, Application and Specification<br />
10.7.2.1 Type I<br />
10.7.2.2 Type II<br />
10.7.3 Biocon (India) <strong>Recombinant</strong> <strong>Protein</strong> Sales, Revenue, Price and Gross Margin<br />
(2011-<strong>2016</strong>)<br />
10.7.4 Main Business/Business Overview<br />
10.8 Eli Lilly (US)<br />
10.8.1 Company Basic Information, Manufacturing Base and Competitors<br />
10.8.2 <strong>Recombinant</strong> <strong>Protein</strong> Product Type, Application and Specification<br />
10.8.2.1 Type I<br />
10.8.2.2 Type II<br />
10.8.3 Eli Lilly (US) <strong>Recombinant</strong> <strong>Protein</strong> Sales, Revenue, Price and Gross Margin<br />
(2011-<strong>2016</strong>)<br />
10.8.4 Main Business/Business Overview<br />
10.9 F. Hoffmann-La Roche Ltd. (Switzerland)<br />
10.9.1 Company Basic Information, Manufacturing Base and Competitors<br />
10.9.2 <strong>Recombinant</strong> <strong>Protein</strong> Product Type, Application and Specification<br />
10.9.2.1 Type I<br />
10.9.2.2 Type II<br />
10.9.3 F. Hoffmann-La Roche Ltd. (Switzerland) <strong>Recombinant</strong> <strong>Protein</strong> Sales, Revenue, Price<br />
and Gross Margin (2011-<strong>2016</strong>)<br />
10.9.4 Main Business/Business Overview<br />
10.10 Genentech (US)<br />
10.10.1 Company Basic Information, Manufacturing Base and Competitors<br />
10.10.2 <strong>Recombinant</strong> <strong>Protein</strong> Product Type, Application and Specification<br />
10.10.2.1 Type I<br />
10.10.2.2 Type II<br />
10.10.3 Genentech (US) <strong>Recombinant</strong> <strong>Protein</strong> Sales, Revenue, Price and Gross Margin<br />
(2011-<strong>2016</strong>)<br />
10.10.4 Main Business/Business Overview<br />
10.11 Janssen Biotech, Inc. (US)<br />
10.12 Kemwell Biopharma (India)<br />
10.13 Novartis (Switzerland)<br />
10.14 Sun Pharmaceutical Industries Ltd. (India)<br />
10.15 Sanofi S.A. (France)<br />
11 <strong>Recombinant</strong> <strong>Protein</strong> Manufacturing Cost Analysis
Change language